About

Publications While At HealthPartners

selected publications

Journal Article

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. 

Lancet Oncology. 2018

North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma. 

Cancer. 2017

Contact

full name

M. R. Mahoney

Quick Info

 

Collaboration

Co-author network

Map of science